The Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration

• Main Authors: A. F. Yusupov (Author), M. Kh. Karimova (Author), S. A. Djamalova (Author), D. K. Makhkamova (Author), S. I. Abdullaeva (Author), M. A. Zakirkhodjaeva (Author), Khodjaeva Zilola (Author), D. A. Rakhimova (Author)
• Format: Book
• Published: Ukrainian Society of Ophthalmologists, 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim. To evaluate the short-term efficacy of using a monoclonal antibody fragment (Brolucizumab) for treating neovascular age-related macular degeneration, depending on the morphometric parameters of the retina. Methods: This study included 48 patients (60 eyes) diagnosed with neovascular age-related...